About US
Contact us
-
Bayer homes in on €10B plastics IPO with plans for summer roadshowBayeris gearing up to spin off its plastics unit and become a life-sciences-focused company, and as part of that prep, it's going on an investor roadshow to seek feedback on its plans. Baye2015/7/21
-
CFDA issues Rules for Classification of Medical DevicesChina Food and Drug Administration (CFDA) recently issued the Rules for Classification of Medical Devices, which will be implemented as of January 1, 20162015/7/20
-
Amgen's Blincyto puts leukemia patients in remission, building its case for a new FDA nodAmgen's ($AMGN) working to expand the label of cancer-fighterBlincyto, and on that front, it's got some solid new data to help it make its case. In a Phase II study, a "clinically meaningful" number2015/7/20
-
Eisai turns North Carolina facility over to Biogen as it continues its cost-cuttingEisaihas been whittling down its U.S. workforce as part of broader cost-cutting moves in the face of a tough patent cliff go. Now the Japanese drugmaker will trim another 135 people from its payroll w2015/7/20
-
Specialty pharmacies don't always live up to their billing: NYTAs payers steer patients toward their own pharmacies and drugmakers opt to distribute their meds solely through specialty channels, service problems are interfering with patient refills and threatenin2015/7/17
-
Endo whistleblower nabs $33.6M from feds for 'extraordinary' work in FCA suitFormer Endosales rep Peggy Ryan first filed a whistleblower suit--concerning off-label marketing of its pain patch, Lidoderm--against the drugmaker in 2005. Nine years later, the company settled with2015/7/17
-
UPDATED: Lilly's Alimta gets rating boost in update to ASCO's drug scorecardWhen theAmerican Society of Clinical Oncologyunveiled its scheme for assessing the value of cancer drugs, it included some less-than-flattering drug ratings. One of those was for Eli Lilly's ($LLY)Ali2015/7/16
-
'Modern Family' star signs on with BMS for immuno-oncology awarenessPharma-watchers may be very familiar with immuno-oncology, what with two hot new cancer drugs already making waves and plenty of others still in the pipeline following behind them. But the average Ame2015/7/16
-
CFDA Minister Bi Jingquan meets French Ambassador to ChinaOn the afternoon of July 13, 2015, Bi Jingquan, Minister of China Food and Drug Administration (CFDA), met with the delegation led by Mr. Maurice Gourdault-Montagne, the French Ambassador to China. Bo2015/7/15
-
FDA slaps Emcure with import alert, adding to ban on Indian plantsTheFDAhas banned yet another Indian drug plant. An import alert for all human and animal drugs from an Emcure Pharmaceuticals plant in Hinjawadi, with a few exceptions, was issued on Monday, according2015/7/15